cyanophenphos: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 25669 |
| CHEMBL ID | 2271087 |
| CHEBI ID | 82112 |
| SCHEMBL ID | 119236 |
| MeSH ID | M0043097 |
| Synonym |
|---|
| 13067-93-1 |
| o-ethyl o-4-cyanophenyl phenylphosphonothioate |
| ent 25,832-a |
| experimental insecticide s-4087 |
| ai3-25832 |
| stauffer b-10094 |
| (+)-phenylphosphonothioic acid o-(4-cyanophenyl) o-ethyl ester |
| cyanofenphos [iso] |
| b-10094 |
| phosphonothioic acid, phenyl-, o-ethyl ester, o-ester with p-hydroxybenzonitrile |
| cp 19699 |
| (+)-cyanofenphos |
| (+-)-phenylphosphonothioic acid o-(4-cyanophenyl) o-ethyl ester |
| brn 2945855 |
| o-p-cyanophenyl o-ethyl phenyl-phosphonothioate |
| phosphonothioic acid, phenyl-, o-(4-cyanophenyl) o-ethyl ester, (+-)- |
| o-ethyl phenylphosphonothioate, o-ester with p-hydroxybenzonitrile |
| upjohn u-32714 |
| (-)-phenylphosphonothioic acid o-(4-cyanophenyl) o-ethyl ester |
| s 4087 |
| surecide |
| phosphonothioic acid, phenyl-, o-(4-cyanophenyl) o-ethyl ester |
| (+-)-cyanofenphos |
| monsanto cp-19699 |
| cyanofenphos |
| o-(4-cyanophenyl) o-ethyl phenylphosphonothioate |
| ent 25,832 |
| (-)-cyanofenphos |
| phenylphosphonothioic acid, o-(4-cyanophenyl) o-ethyl ester |
| phenylphosphonothioic acid o-ethyl ester o-ester with p-hydroxybenzonitrile |
| phosphonothioic acid, phenyl-, o-(4-cyanophenyl) o-ethyl ester, (+)- |
| benzonitrile, p-hydroxy-, o-ester with o-ethyl phenylphosphonothioate |
| cyanophenphos |
| phosphonothioic acid, phenyl-, o-(4-cyanophenyl) o-ethyl ester, (-)- |
| CYP , |
| s-4087 , |
| 4-[ethoxy(phenyl)phosphinothioyl]oxybenzonitrile |
| C18973 |
| unii-1x6jv2ne2n |
| 1x6jv2ne2n , |
| 62421-62-9 |
| 62421-63-0 |
| phosphonothioic acid, phenyl-, 4-cyanophenyl ethyl ester |
| 34460-46-3 |
| 62421-61-8 |
| CHEMBL2271087 |
| chebi:82112 , |
| (rs)-(o-4-cyanophenyl o-ethyl phenylphosphonothioate) |
| o-(4-cyanophenyl) o-ethyl p-phenylphosphonothioate |
| cyanofenphos [mi] |
| SCHEMBL119236 |
| LRNJHZNPJSPMGK-UHFFFAOYSA-N |
| oms 870 |
| surazon |
| b 10094 |
| o-ethyl o-(4-cyanophenyl) phenylphosphonothioate |
| DTXSID5041805 |
| J-005854 |
| cyanofenphos 10 microg/ml in isooctane |
| Q26841289 |
| cyanofenphos 1000 microg/ml in acetone |
| cyanofenphos 1000 microg/ml in methanol |
| Excerpt | Reference | Relevance |
|---|---|---|
| " The oral LD50 for formulated cyanofenphos was 700 mg/kg in the control hens and 1170 mg/kg in the hens pretreated with 10 mg/kg daily for 8 days." | ( Protective effect of pretreatment against the acute toxicity of formulated cyanofenphos in hens. Fukushima, M; Konno, N; Yamaguchi, Y; Yamauchi, T, 1984) | 0.27 |
| Excerpt | Relevance | Reference |
|---|---|---|
| "The susceptibility of wild mallard ducklings to the delayed neurotoxic effect of the neurotoxic organophosphorus insecticides cyanofenphos and leptophos was evaluated following a daily dosing regimen." | ( Delayed neurotoxicity in the wild mallard duckling caused by the organophosphorus insecticides cyanofenphos and leptophos. Ahmed, NS; el-Bakary, AS; el-Gendy, KS; el-Sebae, AH; Soliman, SA, 1986) | 0.27 |
| " Surviving ducks of this group completely recovered from the cholinergic effect 2 or 3 d after finishing the dosing regimen." | ( Delayed neuropathy in adult Peking ducks induced by some organophosphorus esters. Farmer, JD; Soliman, SA, 1984) | 0.27 |
| Class | Description |
|---|---|
| nitrile | A compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it. |
| benzenes | Any benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.96) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||